Quantitative, competitive PCR assay for HIV-1 using a microplate-based detection system

被引:32
作者
Guenthner, PC [1 ]
Hart, CE [1 ]
机构
[1] Ctr Dis Control & Prevent, Atlanta, GA USA
关键词
D O I
10.2144/98245dt01
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We have developed a quantitative competitive PCR (QC-PCR) assay in a microplate format for quantifying human immunodeficiency virus Type 1 (HIV-1) DNA or RNA in a broad range of source materials. Our QC-PCR assay is a modification of technique originally described by Piatak et al. (1993), which is based on the presence of a competitive internal standard containing an internal 80-bp deletion of HIV-1 gag target sequence. For improved detection and quantification of the wild-type and internal-standard PCR products in a microplate format, we introduced a non-HIV, 31-bp insert into the internal standard as a probe hybridization site that does not cross-hybridize with wild-type HIV-1 products. By using a primer pair in which one primer is biotinylated, QC-PCRs can be bound to a streptavidin-coated microplate, denatured and probed with a digoxigenin (Dig)-labeled, wild-type or internal-standard probe. The hybridized Dig-labeled probes ar detected with an anti-Dig antibody conjugated to detector molecules for luminometry (aequorin) or optical densitometry (Peroxidase), yielding results that are quantifiable over the rang of 100-10 000 copies of HIV gag. Tested source materials for HIV-1 DNA or RNA quantification include plasma, vaginal lavage and cultured cells. The application of the QC-PCR assay using the microplate format affords a convenient and cost-effective method for quantifying HIV-1 proviral and viral loads from a variety of body fluids, cells and tissues.
引用
收藏
页码:810 / 816
页数:7
相关论文
共 30 条
[1]   SPECIFICITY OF POLYMERASE CHAIN AMPLIFICATION REACTIONS FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 DNA-SEQUENCES [J].
BELL, J ;
RATNER, L .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1989, 5 (01) :87-95
[2]   CLINICAL-EVALUATION OF BRANCHED DNA SIGNAL AMPLIFICATION FOR QUANTIFYING HIV TYPE-1 IN HUMAN PLASMA [J].
CAO, YZ ;
HO, DD ;
TODD, J ;
KOKKA, R ;
URDEA, M ;
LIFSON, JD ;
PIATAK, M ;
CHEN, S ;
HAHN, BH ;
SAAG, MS ;
SHAW, GM .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (03) :353-361
[3]   IMPROVED DETECTION OF HIV-1 ENVELOPE SEQUENCES USING OPTIMIZED PCR AND INOSINE-SUBSTITUTED PRIMERS [J].
CASSOL, S ;
SALAS, T ;
LAPOINTE, N ;
ARELLA, M ;
RUDNIK, J ;
OSHAUGHNESSY, M .
MOLECULAR AND CELLULAR PROBES, 1991, 5 (02) :157-160
[4]   PLASMA VIREMIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTION [J].
COOMBS, RW ;
COLLIER, AC ;
ALLAIN, JP ;
NIKORA, B ;
LEUTHER, M ;
GJERSET, GF ;
COREY, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) :1626-1631
[5]   THE ENZYMOLOGY AND MOLECULAR-BIOLOGY OF THE CA-2+-ACTIVATED PHOTOPROTEIN, AEQUORIN [J].
CORMIER, MJ ;
PRASHER, DC ;
LONGIARU, M ;
MCCANN, RO .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1989, 49 (04) :509-512
[6]   New approaches to using antiretroviral therapy for the management of HIV infection [J].
Doran, CM .
ANNALS OF PHARMACOTHERAPY, 1997, 31 (02) :228-236
[7]   BIOLOGICAL AND BIOCHEMICAL-CHARACTERIZATION OF A CLONED LEU-3- CELL SURVIVING INFECTION WITH THE ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME RETROVIRUS [J].
FOLKS, TM ;
POWELL, D ;
LIGHTFOOTE, M ;
KOENIG, S ;
FAUCI, AS ;
BENN, S ;
RABSON, A ;
DAUGHERTY, D ;
GENDELMAN, HE ;
HOGGAN, MD ;
VENKATESAN, S ;
MARTIN, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (01) :280-290
[8]  
Harrigan R, 1995, J ACQ IMMUN DEF SYND, V10, pS34
[9]  
HART RC, 1993, BIOLUMINESCENCE CHEM, P320
[10]   THE NATURAL-HISTORY OF HIV-1 INFECTION - VIRUS LOAD AND VIRUS PHENOTYPE INDEPENDENT DETERMINANTS OF CLINICAL COURSE [J].
JURRIAANS, S ;
VANGEMEN, B ;
WEVERLING, GJ ;
VANSTRIJP, D ;
NARA, P ;
COUTINHO, R ;
KOOT, M ;
SCHUITEMAKER, H ;
GOUDSMIT, J .
VIROLOGY, 1994, 204 (01) :223-233